Abstract: Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues.
Type:
Grant
Filed:
October 25, 2013
Date of Patent:
March 31, 2015
Assignee:
Alcon Pharamceuticals, Ltd.
Inventors:
Gerald Cagle, Robert L. Abshire, David W. Stroman, John M. Yanni